174 related articles for article (PubMed ID: 27225198)
1. Malfunctioned cardiac resynchronization therapy attributed to acute exacerbation of cardiac sarcoidosis.
Ikeda S; Ohtani K; Uwatoku T; Higo T
Eur Heart J; 2016 Sep; 37(33):2613. PubMed ID: 27225198
[No Abstract] [Full Text] [Related]
2. Effect of Corticosteroid Dose and Duration on 18-Fluorodeoxyglucose Positron Emission Tomography in Cardiac Sarcoidosis.
Okada DR; Saad E; Wand AL; Griffin JM; Kasper EK; Chen EH; Chrispin J; Tandri H; Solnes LB; Gilotra NA
JACC Cardiovasc Imaging; 2020 May; 13(5):1280-1282. PubMed ID: 31954655
[No Abstract] [Full Text] [Related]
3. Long-Term Corticosteroid-Sparing Immunosuppression for Cardiac Sarcoidosis.
Rosenthal DG; Parwani P; Murray TO; Petek BJ; Benn BS; De Marco T; Gerstenfeld EP; Janmohamed M; Klein L; Lee BK; Moss JD; Scheinman MM; Hsia HH; Selby V; Koth LL; Pampaloni MH; Zikherman J; Vedantham V
J Am Heart Assoc; 2019 Sep; 8(18):e010952. PubMed ID: 31538835
[TBL] [Abstract][Full Text] [Related]
4. Images in cardiovascular medicine. Multimodality imaging of cardiac sarcoidosis before and after steroid therapy.
Tadamura E; Yamamuro M; Kubo S; Kanao S; Hosokawa R; Kimura T; Kita T; Togashi K
Circulation; 2006 May; 113(20):e771-3. PubMed ID: 16717157
[No Abstract] [Full Text] [Related]
5. Cardiac Sarcoidosis Concomitant with Large-vessel Aortitis Detected by
Higuchi Y; Kimoto Y; Tanoue R; Tokunou T; Tomonari K; Maeda T; Horiuchi T
Intern Med; 2018 Jun; 57(11):1601-1604. PubMed ID: 29321427
[TBL] [Abstract][Full Text] [Related]
6. Treating Myocardial Inflammation in Cardiac Sarcoidosis: Why, With What, and for How Long?
Blankstein R; Divakaran S
JACC Cardiovasc Imaging; 2022 Nov; 15(11):1956-1959. PubMed ID: 36357137
[No Abstract] [Full Text] [Related]
7. Cardiac sarcoidosis: the complementary role of 18F-FDG PET and MRI.
Van Schandevyl S; Waterschoot R; De Vos N; Devos D; Goethals I
J Cardiovasc Med (Hagerstown); 2020 Apr; 21(4):335-336. PubMed ID: 31809284
[No Abstract] [Full Text] [Related]
8. (18)F-FDG PET/CT for the assessment of myocardial sarcoidosis.
Skali H; Schulman AR; Dorbala S
Curr Cardiol Rep; 2013 May; 15(5):352. PubMed ID: 23504346
[TBL] [Abstract][Full Text] [Related]
9. Acute inflammatory pericarditis secondary to cardiac sarcoidosis evaluated by 18F-fluorodeoxyglucose PET/CT imaging.
AlBassam O; Redwood T; Bowers N; Iwanochko R
J Nucl Cardiol; 2021 Apr; 28(2):763-767. PubMed ID: 32095937
[No Abstract] [Full Text] [Related]
10. Fluorodeoxyglucose Myocardial Accumulation to Assess Response to Immunosuppressive Treatment in Cardiac Sarcoidosis.
Cooper LT; Reddy P
JACC Cardiovasc Imaging; 2024 Jan; 17(1):59-61. PubMed ID: 37656116
[No Abstract] [Full Text] [Related]
11. Prednisone vs methotrexate in treatment naïve cardiac sarcoidosis.
Vis R; Mathijssen H; Keijsers RGM; van de Garde EMW; Veltkamp M; Akdim F; Post MC; Grutters JC
J Nucl Cardiol; 2023 Aug; 30(4):1543-1553. PubMed ID: 36640249
[TBL] [Abstract][Full Text] [Related]
12. Extrapulmonary Sarcoidosis in the Orbit, Brain, and Heart.
Park SSE; Akella S; Kumthekar A; Barmettler A
Am J Med; 2020 Jun; 133(6):e298-e299. PubMed ID: 31862334
[No Abstract] [Full Text] [Related]
13. FDG-PET and MIBI-Tc SPECT as follow-up tools in a patient with cardiac sarcoidosis requiring a pacemaker.
Smedema JP; White L; Klopper AJ
Cardiovasc J Afr; 2008; 19(6):309-10. PubMed ID: 19104727
[TBL] [Abstract][Full Text] [Related]
14. Cardiac sarcoidosis - silent destroyer.
Martusewicz-Boros MM; Piotrowska-Kownacka D; Wiatr E; Roszkowski-Śliż K
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Aug; 33(2):175-7. PubMed ID: 27537722
[TBL] [Abstract][Full Text] [Related]
15. [Usefulness of fluorine-18 fluoro-2-deoxyglucose positron emission tomography for diagnosis and therapy assessment of cardiac sarcoidosis].
Ishida Y; Nakatani S; Tachibana T
J Cardiol; 2000 Apr; 35(4):301-4. PubMed ID: 10791274
[No Abstract] [Full Text] [Related]
16. [Cardiac sarcoidosis detected by FDG-PET].
Goto K; Okamoto E; Morita M; Sasamoto T; Endo M; Umezawa K; Suguta M; Kaneko Y; Nakano A; Arai M; Hasegawa A; Kurabayashi M
Nihon Naika Gakkai Zasshi; 2005 Jul; 94(7):1396-8. PubMed ID: 16097596
[No Abstract] [Full Text] [Related]
17. Sarcoidosis manifesting as cardiac sarcoidosis and massive splenomegaly.
Kawano S; Kato J; Kawano N; Yoshimura Y; Masuyama H; Fukunaga T; Shimao Y; Mihara K; Ueda A; Toyoda K; Imamura T; Kitamura K
Intern Med; 2012; 51(1):65-9. PubMed ID: 22214625
[TBL] [Abstract][Full Text] [Related]
18. The role of F18-fluorodeoxyglucose positron emission tomography in identifying patients at high risk for lethal arrhythmias from cardiac sarcoidosis and the use of serial scanning to guide therapy.
Paz YE; Bokhari S
Int J Cardiovasc Imaging; 2014 Feb; 30(2):431-8. PubMed ID: 24293048
[TBL] [Abstract][Full Text] [Related]
19. Cardiac magnetic resonance imaging-indeterminate/negative cardiac sarcoidosis revealed by
Sasson SC; Russo R; Chung T; Chu G; Hunyor I; Williamson J; Murad A; Kane A; Riminton S; Limaye S
J Med Case Rep; 2017 Oct; 11(1):291. PubMed ID: 29052526
[TBL] [Abstract][Full Text] [Related]
20. Second left ventricular aneurysm newly developed in a patient with untreated cardiac sarcoidosis.
Sato T; Kanzaki H; Ishida Y; Amaki M; Ohara T; Hasegawa T; Hashimura K; Nakatani S; Yamada N; Ikeda Y; Ueda-Ishibashi H; Kitakaze M
Circ J; 2010 Nov; 74(11):2477-8. PubMed ID: 20890051
[No Abstract] [Full Text] [Related]
[Next] [New Search]
